- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 20, 2026 | 20.12M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 20.12M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 756.61K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.69M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $2.32M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.47M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$1.45M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$2.56M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $30.79M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $31.99M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.35M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $6.19M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.5M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $6.34M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.96M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $3.39M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.05M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $3.78M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.13 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$3.40 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.13 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$3.40 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.68M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $1.58M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.49M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$2.75M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.69M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$1.59M |